Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1
- 10 March 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 59 (6) , 2704-2717
Abstract
There is interest in the identification and optimization of new molecular entities selectively targeting ion channels of therapeutic relevance. Peptide toxins represent a rich source of pharmacology for ion channels, and we recently reported GpTx-1 analogs that inhibit NaV1.7, a voltage-gated sodium ion channel that is a compelling target for improved treatment of pain. Here we utilize multi-attribute positional scan (MAPS) analoging, combining high-throughput synthesis and electrophysiology, to interrogate the interaction of GpTx-1 with NaV1.7 and related NaV subtypes. After one round of MAPS analoging, we found novel substitutions at multiple residue positions not previously identified, specifically glutamic acid at positions 10 or 11 or lysine at position 18, that produce peptides with single digit nanomolar potency on NaV1.7 and 500-fold selectivity against off-target sodium channels. Docking studies with a NaV1.7 homology model and peptide NMR structure generated a model consistent with the key potency and selectivity modifications mapped in this work.Keywords
This publication has 43 references indexed in Scilit:
- Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund’s Adjuvant Models of PainPLOS ONE, 2015
- Global Nav1.7 Knockout Mice Recapitulate the Phenotype of Human Congenital Indifference to PainPLOS ONE, 2014
- Paroxysmal itch caused by gain-of-function Nav1.7 mutationPain, 2014
- NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both DisordersJournal of Neuroscience, 2008
- A stop codon mutation in SCN9A causes lack of pain sensationHuman Molecular Genetics, 2007
- Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populationsClinical Genetics, 2007
- An SCN9A channelopathy causes congenital inability to experience painNature, 2006
- Nav1.7 Mutant A863P in Erythromelalgia: Effects of Altered Activation and Steady-State Inactivation on Excitability of Nociceptive Dorsal Root Ganglion NeuronsThe Journal of Neuroscience, 2006
- Overview of Molecular Relationships in the Voltage-Gated Ion Channel SuperfamilyPharmacological Reviews, 2005
- Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgiaJournal of Medical Genetics, 2004